Skip to main content

Medical Education

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angel Pharmaceuticals
Angel PharmaceuticalsChina - Zhejiang
1 program
Community Service-Learning Anthropometric AssessmentN/A1 trial
Active Trials
NCT07528521Not Yet Recruiting35Est. May 2026
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
NbB psychopharmacology trainingN/A1 trial
Active Trials
NCT04375254Unknown100Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angel PharmaceuticalsCommunity Service-Learning Anthropometric Assessment
Jerusalem PharmaceuticalsNbB psychopharmacology training

Clinical Trials (2)

Total enrollment: 135 patients across 2 trials

NCT07528521Angel PharmaceuticalsCommunity Service-Learning Anthropometric Assessment

Effect of a Community Service-Learning Intervention on Medical Empathy and Clinical Self-Efficacy in Medical Students

Start: Apr 2026Est. completion: May 202635 patients
N/ANot Yet Recruiting
NCT04375254Jerusalem PharmaceuticalsNbB psychopharmacology training

Neuroscience-based Nomenclature (NbN) as a Teaching Tool

Start: May 2020Est. completion: Sep 2021100 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.